Executive record

William Doyle

Director at NovoCure Ltd

Follow
More
Challenge a Claim

Alpha ID: alpha:person:william-doyleVersion: public-0As of: 2026-09-28

Not yet claimed8 published Claims3 sources
  • Director

Key Claims

Biography

Mr. Doyle has served as Executive Chairman since 2016 and as a Board member since 2004, previously serving as managing director of WFD Ventures LLC and holding senior roles at Johnson & Johnson including VP of Licensing and Acquisitions. He also previously served as Executive Chairman of BlinkHealth LLC and is currently a director of Elanco Animal Health and ProKidney.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Claims

Executive career

  1. 2026 to end not publishedExecutive title: Executive Chairman and Director · Organization not publishedNVCR 10-K executive officers

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Open source

    sec proxy · Source published: Apr 20, 2026 · Retrieved: Sep 2, 2026

    Supports 1 claim
    • Professional Role: Director at NovoCure Ltd · Claim reviewed: May 5, 2026

  2. NVCR 10-K executive officers

    sec filing · Source published: Feb 26, 2026 · Retrieved: May 5, 2026

    Supports 6 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 5, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 5, 2026
    • Executive company: Executive at NovoCure Ltd · Claim reviewed: May 5, 2026
    • Executive title: Executive title: Executive Chairman and Director · Claim reviewed: May 5, 2026
    • Other Company Role: William Doyle is also linked to Elanco Animal Health, Inc. as Director. · Claim reviewed: May 5, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 5, 2026

  3. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of NovoCure Ltd · Claim reviewed: May 5, 2026